REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,470,450 | -7.7% | 261,277 | +25.2% | 0.00% | 0.0% |
Q2 2023 | $4,844,713 | +89.0% | 208,644 | +43.7% | 0.00% | 0.0% |
Q1 2023 | $2,563,278 | -66.9% | 145,146 | -48.9% | 0.00% | -50.0% |
Q4 2022 | $7,733,096 | +1592.1% | 284,305 | +974.3% | 0.00% | – |
Q3 2022 | $457,000 | -41.6% | 26,463 | -40.9% | 0.00% | – |
Q2 2022 | $782,000 | +2.9% | 44,759 | 0.0% | 0.00% | – |
Q1 2022 | $760,000 | -88.6% | 44,759 | -81.7% | 0.00% | -100.0% |
Q4 2021 | $6,646,000 | -38.7% | 245,251 | -33.0% | 0.00% | -50.0% |
Q3 2021 | $10,849,000 | -23.0% | 366,009 | -0.1% | 0.00% | 0.0% |
Q2 2021 | $14,081,000 | – | 366,502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |